Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Wendy Stock

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Stock, Wendy

Item TypeName
Concept Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Concept Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Academic Article Studies of minimal residual disease in acute lymphocytic leukemia.
Academic Article Progress in the treatment of adults with acute lymphoblastic leukemia.
Academic Article Approaches to treatment for acute lymphoblastic leukemia in adolescents and young adults.
Academic Article Pediatric regimens for adult acute lymphoblastic leukemia.
Academic Article Preface: acute lymphoblastic leukemia--quo vadis?
Academic Article Adult acute lymphoblastic leukemia: concepts and strategies.
Academic Article Children, adolescents, and young adults with leukemia: the empty half of the glass is growing.
Academic Article Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Academic Article Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel.
Academic Article Adolescents and young adults with acute lymphoblastic leukemia.
Academic Article Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
Academic Article What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Academic Article Advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Academic Article Looking toward the future: novel strategies based on molecular pathogenesis of acute lymphoblastic leukemia.
Academic Article A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia.
Academic Article Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia.
Academic Article High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
Academic Article The genomic landscape of hypodiploid acute lymphoblastic leukemia.
Academic Article Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.
Academic Article RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.
Academic Article Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
Academic Article A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.
Academic Article Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance).
Academic Article How I treat acute lymphoblastic leukemia in older adolescents and young adults.
Academic Article Novel drug targets in acute leukemia.
Academic Article Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).
Academic Article Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Academic Article Intergroup Trial C10403: A Pediatric Treatment Approach to Improve Outcomes in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.
Academic Article Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.
Academic Article Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
Academic Article Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
Academic Article An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia.
Academic Article Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Academic Article Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).
Academic Article High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.
Academic Article Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Academic Article The Persistence of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?
Academic Article Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
Academic Article Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Academic Article Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE.
Academic Article Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach.
Academic Article Progress in adult ALL: incorporation of new agents to frontline treatment.
Academic Article Should immunologic strategies be incorporated into frontline ALL therapy?
Academic Article Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
Academic Article Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study.
Academic Article Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.
Academic Article Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia.
Academic Article Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Academic Article Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens.
Academic Article Management of acute lymphoblastic leukemia in young adults.
Academic Article Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia.
Academic Article Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin.
Academic Article PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Academic Article A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
Academic Article Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL.
Academic Article Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.
Academic Article Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.
Academic Article Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.
Academic Article Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Academic Article Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial.
Academic Article Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
Academic Article Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.
Academic Article Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
Academic Article Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study database.
Academic Article Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.
Academic Article Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study.
Academic Article Thrombosis in ALL: a risk without clear mitigation.
Academic Article Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden.
Academic Article Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin.
Academic Article Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia.
Academic Article Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Academic Article Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemia.
Academic Article Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
Academic Article Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22.
Academic Article Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Academic Article Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.
Academic Article Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.
Academic Article Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.
Academic Article The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.
Academic Article Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL.
Academic Article SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.
Academic Article Optimizing use of L-asparaginase-based treatment of adults with acute lymphoblastic leukemia.
Academic Article SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Academic Article MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia.
Academic Article Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Academic Article Updates in the Management of Relapsed and Refractory Acute Lymphoblastic Leukemia: An Urgent Plea for New Treatments Is Being Answered!
Academic Article Acute lymphoblastic leukemia displays a distinct highly methylated genome.
Academic Article Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
Academic Article Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia.
Academic Article Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents.
Academic Article D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia.
Academic Article Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
Academic Article Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.

Search Criteria
  • Acute Lymphoblastic Leukemia